Recent studies have linked elevated PRMT5 levels to a variety of human disorders, particularly cancers, including lung cancer, breast cancer, leukemia, lymphoma, gastric cancer, and colorectal cancer [60, 61]. This evidence concerns the gene PRMT5 and leukemia.